What are Allergen immunotherapy vaccine drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Allergen immunotherapy vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting House dust mite allergens (Der p 1, Der p 2, Der f 1, Der f 2)). 0 are currently marketed, with 3 more in clinical development.

Allergen immunotherapy vaccine

0 marketed 2 in Phase 3 1 in Phase 2

This page covers all Allergen immunotherapy vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting House dust mite allergens (Der p 1, Der p 2, Der f 1, Der f 2), House dust mite allergens (Der p 1, Der p 2, and other HDM proteins).

Targets

House dust mite allergens (Der p 1, Der p 2, Der f 1, Der f 2) · House dust mite allergens (Der p 1, Der p 2, and other HDM proteins)

Phase 3 pipeline (2)

ALK HDM AIT 6 DU · ALK-Abelló A/S · Immunology / Allergy
ALK HDM AIT 6 DU is an allergen immunotherapy (AIT) vaccine that desensitizes the immune system to house dust mite (HDM) allergens through repeated subcutaneous administration.
ALK HDM AIT 12 DU · ALK-Abelló A/S · Immunology / Allergy
ALK HDM AIT 12 DU is an allergen immunotherapy (AIT) vaccine that desensitizes the immune system to house dust mite (HDM) allergens through repeated subcutaneous administration.

Phase 2 pipeline (1)

Allergovac Poliplus · Roxall Medicina España S.A · Immunology / Allergy
Allergovac Poliplus is an allergen immunotherapy vaccine designed to desensitize the immune system to multiple allergens through controlled exposure.

Patent intelligence

allergen immunotherapy vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates